The Hidden Connection: How Your Gut Microbiome Influences Mood and Energy

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

The gut microbiome—the ecosystem of microorganisms residing in your digestive tract—plays an important role in regulating mood, cognitive function, and energy levels through immune signalling, neurotransmitter production, and communication along the gut–brain axis (1–3). When this system becomes disrupted, including through dysbiosis or increased intestinal permeability, it has been associated with symptoms such as fatigue, low mood, anxiety, and brain fog, even when routine blood tests fall within reference ranges (4–7).

The Core Concept: The Gut–Brain Axis Explained

The gut–brain axis describes the bidirectional communication network linking the gastrointestinal tract and the central nervous system via neural, immune, endocrine, and metabolic pathways (1,2). A key component of this network is the vagus nerve, which transmits sensory information from the gut to the brain and helps regulate stress responses, inflammatory signalling, and emotional regulation (8).

The gut microbiome contributes to this communication by producing bioactive metabolites, influencing immune activity, and modulating neurotransmitter synthesis (3,9). When microbial balance is disrupted—a state known as dysbiosis—these signalling pathways may become altered, contributing to low-grade inflammation and changes in brain function (4,6). For a deeper explanation of how microbial balance affects systemic health, see our overview of the gut microbiome.

Why Gut Health Affects Mood and Energy

Approximately 90% of the body’s serotonin is synthesised in the gastrointestinal tract, largely under microbial influence (10). Serotonin plays a role in mood regulation, motivation, sleep, and gastrointestinal motility. Alterations in gut microbial composition have been associated with changes in serotonin signalling and behavioural outcomes (10–12).

Dysbiosis has also been linked to systemic inflammation, dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, and impaired cellular energy metabolism—mechanisms that may contribute to fatigue, reduced stress tolerance, and cognitive slowing (5–7,13). These processes are commonly explored in people seeking support for chronic fatigue and persistent low energy.

Intestinal Permeability and Neuroinflammation

The intestinal lining functions as a selective barrier, allowing nutrients to pass into circulation while limiting the translocation of microbes and toxins. When this barrier becomes compromised—often described as increased intestinal permeability—microbial components such as lipopolysaccharides may enter the bloodstream and activate inflammatory pathways (14,15).

Systemic inflammation has been associated with changes in blood–brain barrier integrity and neuroinflammatory signalling. Rather than presenting as acute neurological symptoms, this process may manifest more subtly as brain fog, anxiety, irritability, or persistent low mood (6,15,16), which overlaps with mechanisms discussed in our mental health resource.

When to Consider a Gut–Brain Contribution

A gut–brain contribution may be worth exploring if symptoms include:

• Persistent bloating, constipation, diarrhoea, or abdominal discomfort
• Ongoing fatigue not explained by routine investigations
• Low mood, anxiety, or emotional reactivity without a clear psychological trigger
• Difficulty concentrating, reduced mental clarity, or memory issues

Why Functional Gut Testing Can Help

Conventional investigations are designed to detect overt disease rather than assess microbial diversity, metabolic activity, or immune interactions. Comprehensive stool and microbiome analyses can offer insight into microbial balance, digestive function, and inflammatory patterns, allowing interventions to be guided by individual biological findings rather than symptoms alone (17–19). This approach reflects how we use functional testing within our integrative care model.

Next Steps: A Layered, Individualised Approach

When gut involvement is identified, support strategies are typically staged and individualised. These may include:

• Targeted microbial modulation when specific overgrowth patterns are identified (20)
• Selective probiotic or prebiotic support, chosen based on tolerance and microbial requirements (11,21)
• Nutritional support for gut barrier integrity, including nutrients involved in epithelial repair and maintenance (22)
• Stress and sleep regulation to support vagal tone and circadian rhythm stability (8,23)

Key Insights

• The gut and brain are closely interconnected through immune, neural, and metabolic pathways
• Dysbiosis and increased intestinal permeability have been associated with fatigue, mood disturbance, and cognitive symptoms
• Targeted assessment may help explain symptoms that persist despite “normal” routine test results

When Gut Health May Be Part of the Picture

If you’re experiencing persistent fatigue, low mood, or brain fog without clear answers, exploring gut health may provide valuable context. A structured, evidence-informed approach can help clarify whether gut–brain interactions are contributing to your symptoms and guide appropriate next steps.

1. Carabotti M et al. The gut–brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015.
2. Grenham S et al. Brain–gut–microbe communication in health and disease. Front Physiol. 2011.
3. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012.
4. Foster JA et al. Gut microbiota and brain function: an evolving field in neuroscience. Int J Neuropsychopharmacol. 2016.
5. Dinan TG, Cryan JF. Gut microbiota: a missing link in psychiatry. World Psychiatry. 2020.
6. Kelly JR et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes. J Psychiatr Res. 2016.
7. Maes M et al. Increased intestinal permeability in chronic fatigue syndrome. Neuro Endocrinol Lett. 2007.
8. Bonaz B et al. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease. J Intern Med. 2016.
9. Koh A et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016.
10. Yano JM et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015.
11. Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans. Ann Gen Psychiatry. 2017.
12. O’Mahony SM et al. Serotonin, tryptophan metabolism and the brain–gut–microbiome axis. Behav Brain Res. 2015.
13. Naviaux RK et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016.
14. Bischoff SC et al. Intestinal permeability—a new target for disease prevention and therapy. BMC Gastroenterol. 2014.
15. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012.
16. Haruwaka K et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation. Proc Natl Acad Sci USA. 2019.
17. Marchesi JR et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016.
18. Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018.
19. Quigley EMM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013.
20. Spanogiannopoulos P et al. The microbial pharmacists within us. Nat Rev Microbiol. 2016.
21. Sarkar A et al. Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci. 2016.
22. Rao R, Samak G. Role of glutamine in protection of intestinal epithelial tight junctions. J Epithel Biol Pharmacol. 2012.
23. Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019.